Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53

Genes and Development

Volumn 13, Issue 10, 1999, Pages 1240-1245

  Nozawa, Hiroaki ^a   Oda, Eri ^a   Nakao, Kazuki ^b   Ishihara, Masahiko ^a   Ueda, Seiji ^a   Yokochi, Taeko ^a   Ogasawata, Kouetsu ^a   Nakatsuru, Yoko ^a   Shimizu, Seiichito ^a   Ohira, Yoshikazu ^a   Hioki, Kyoji ^c   Aizawa, Shinichi ^d   Ishikawa, Takatoshi ^a   Katsuki, Motoya ^b   Muto, Tetsuichiro ^a   Taniguchi, Tadatsugu ^a   Tanaka, Nobuyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

c Ha ras; IRF 1; Mutation frequency; p53; Tumor susceptibility gene

Indexed keywords

INTERFERON REGULATORY FACTOR 1; PROTEIN P53; TRANSCRIPTION FACTOR;

ALLELE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL TRANSFORMATION; CHIMERA; FEMALE; GENE EXPRESSION; GENE LOSS; GENE MUTATION; MALE; MOUSE; MUTATION RATE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; ZYGOSITY;

ANIMALIA; RODENTIA;

EID: 0033563225     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.10.1240     Document Type: Article

References (40)

1. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86: 159-171.
2. Buckwalter, M.S., A.C. Lossie, L.M. Scarlett, and S.A. Camper. 1992. Localization of the human chromosome 5q genes Gabra-1, Gabrg-2, 11-4, 115, and Irf-1 on mouse chromosome 11. Mamm. Genome 3: 604-607.
3. Demant, P. 1992. Genetic resolution of susceptibility to cancer - New perspectives. Semin. Cancer Biol. 3: 159-166.
4. Dietrich, W.F., E.S. Lander, J.S. Smith, A.R. Moser, K.A. Gould, C. Luongo, N. Borenstein, and W. Dove. 1993. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639.
5. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
6. Evan, G. and T. Littlewood. 1998. A matter of life and cell death. Science 281: 1317-1322.
7. Ghebranious, N. and L.A. Donehower. 1998. Mouse models in tumor suppression. Oncogene 17: 3385-3400.
8. Gould, K.A. and W.F. Dove. 1997. Localized gene action controlling intestinal neoplasia in mice. Proc. Nad. Acad. Sci. 94: 5848-5853.
9. ARF. Cell 91: 555-558.
10. Harada, H., T. Kondo, S. Ogawa, T. Tamura, M. Kitagawa, N. Tanaka, M.S. Lamphier, H. Hirai, and T. Taniguchi. 1994. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene 9: 3313-3320.
11. Hawkins, D.S., G.W. Demers, and D.A. Galloway. 1996. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 56: 892-898.
12. Jacks, T. 1996. Lessons from the p53 mutant mouse. J. Cancer Res. Clin. Oncol. 122: 319-327.
13. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
14. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S.I. Koh, T. Kimura, S.J. Green, T.W. Mak, T. Taniguchi, and J. Vlicek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615.
15. Kimura, T., K. Nakayama, J. Penninger, M. Kitagawa, H. Harada, T. Matsuyama, N. Tanaka, R. Kamijo, J. Vilcek, T.W. Mak, and T. Taniguchi. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924.
16. Kinzler, K.W. and B. Vogelstein. 1998. Landscaping the cancer terrain. Science 280: 1036-1037.
17. Lohoff, M., D. Ferrick, H.W. Mittrucker, G.S. Duncan, S. Bischof, M. Rollinghoff, and T.W. Mak. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6: 681-689.
18. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kündig, R. Amakawa, K. Kishihara, A. Wakeham, J. Potter, C.L. Furlonger, A. Narendran, H. Suzuki, P.S. Ohashi, C.J. Paige, T. Taniguchi, and T.W. Mak. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75: 83-97.
19. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54: 903-913.
20. Nagy, A and J. Rossant. 1993. Production of completely ES cell-derived fetus. In Gene targeting, a practical approach (ed. A.L. Joyner), pp. 147-180. IRL Press, Oxford, UK.
21. Nozawa, H., E. Oda, S. Ueda, G. Tamura, C. Maesawa, T. Muto, T. Taniguchi, and N. Tanaka. 1998. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int. J. Cancer 77: 522-527.
22. Ogasawara, S., G. Tamura, C. Maesawa, Y. Suzuki, K. Ishida, N. Satoh, N. Uesugi, K. Saito, and R. Satodate. 1996. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroentemlogy 110: 52-57.
23. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-Fukuda, T.A. Waldmann, T. Taniguchi, and S. Taki. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391: 700-703.
24. Reitmair, A.H., J.C. Cai, M. Bjerknes, M. Redston, H. Cheng, M.T. Pind, K. Hay, A. Mitri, B.V. Bapat, T.W. Mak, and S. Gallinger. 1996. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56: 2922-2926.
25. Rotter, V., D. Wolf, D. Pravtcheva, and F.H. Ruddle. 1984. Chromosomal assignment of the murine gene encoding the transformation-related protein p53. Mol. Cell. Biol 4: 383-385.
26. Saitoh, A., M. Kimura, R. Takahashi, M. Yokoyama, T. Nomura, M. Izawa, T. Sekiya, S. Nishimura, and M. Katsuki. 1990. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195-1200.
27. Sekiguchi, M., Y. Nakabeppu, K. Sakumi, and T. Tuzuki. 1996. DNA-repair methyltransferase as a molecular device for preventing mutation and cancer. J. Cancer Res. Clin. Oncol. 122: 199-206.
28. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
29. Strauss, B.S. 1998. Hypermutability in carcinogenesis. Genetics 148: 1619-1626.
30. Taki, S., T. Sato, K. Ogasawara, T. Fukuda, M. Sato, S. Hida, G. Suzuki, M. Mitsuyama, E.H. Shin, S. Kojima, T. Taniguchi, and Y. Asano. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6: 673-679.
31. Tamura, T., M. Ishihara, M.S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T.W. Mak, S. Taki, and T. Taniguchi. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599.
32. Tamura, G., S. Ogasawara, S. Nishizuka, K. Sakata, C. Maesawa, Y. Suzuki, M. Terashima, K. Saito, and R. Satodate. 1996. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 56: 612-615.
33. Tanaka, K. and R.D. Wood. 1994. Xeroderma pigmentosum and nucleotide excision repair of DNA. Trends Biochem. Sci. 19: 83-86.
34. Tanaka, N., M. Ishihara, M. Kitagawa, H. Harada, T. Kimura, T. Matsuyama, M.S. Lamphier, S. Aizawa, T.W. Mak, and T. Taniguchi. 1994a. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839.
35. Tanaka, N., M. Ishihara, and T. Taniguchi. 1994b. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett. 83: 191-196.
36. Tanaka, N., M. Ishihara, M.S. Lamphier, H. Nozawa, T. Matsuyama, T.W. Mak, S. Aizawa, T. Tokino, M. Oren, and T. Taniguchi. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818.
37. Tsukada, T., Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda, S. Abe, I. Matsuo, Y. Ikawa, and S. Aizawa. 1993. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8: 3313-3322.
38. Westphal, C.H., S. Rowan, C. Schmaltz, A. Elson, D.E. Fisher, and P. Leder. 1997. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet. 16: 397-401.
39. Williams, B.O., L. Remington, D.M. Albert, S. Mukai, R.T. Bronson, and T. Jacks. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7: 480-484.
40. Willman, C.L., C.E. Sever, M.G. Pallavicini, H. Harada, N. Tanaka, M.L. Slovak, H. Yamamoto, K. Harada, T.C. Meeker, A.F. List, and T. Taniguchi. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259: 968-971.